NCAM1 and COVID-19: Comparisons of blood from healthy subjects (unexposed) and patients with COVID-19 revealed that the percentage of circulating NK (CD56+) and CD4+ T cells significantly increased at 20–30 days after the onset of symptoms (Figures 2A, B, D).